{
  "_originalData": {
    "title": "Parvimonas micra",
    "last_updated": "2024-04-29",
    "classification": "Anaerobic gram-positive coccus",
    "clinical_setting": {
      "summary": "This organism is part of the oral and gastrointestinal flora. It is associated with odontogenic infections and, rarely, with bacteremia and abscess formation.",
      "diagnosis": "Indicated by a positive lab result."
    },
    "treatment_regimens": {
      "primary": {
        "susceptibility": "Typically susceptible to Penicillin, Clindamycin, and Metronidazole."
      },
      "alternative": [
        {
          "drug": "A carbapenem"
        }
      ]
    },
    "comments": {
      "references": "See Eur J Clin Microbiol Infect Dis. 2023:42:903 and Microorganisms. 2021:9:1665 for case series and antimicrobial susceptibilities."
    }
  },
  "_metadata": {
    "originalKeys": [
      "title",
      "last_updated",
      "classification",
      "clinical_setting",
      "treatment_regimens",
      "comments"
    ],
    "conversionTimestamp": "2025-07-15T03:16:49.259Z",
    "sourceFormat": "mixed"
  },
  "identity": {
    "bacteriumName": {
      "sources": [
        "title"
      ],
      "value": "Parvimonas micra"
    },
    "aliases": {
      "sources": [
        "aliases"
      ],
      "value": []
    }
  },
  "treatmentData": {
    "treatmentData": {
      "_treatmentMetadata": {
        "originalFormat": "mixed"
      },
      "standardizedRegimens": [],
      "preservedData": {
        "title": "Parvimonas micra",
        "last_updated": "2024-04-29",
        "classification": "Anaerobic gram-positive coccus",
        "clinical_setting": {
          "summary": "This organism is part of the oral and gastrointestinal flora. It is associated with odontogenic infections and, rarely, with bacteremia and abscess formation.",
          "diagnosis": "Indicated by a positive lab result."
        },
        "treatment_regimens": {
          "primary": {
            "susceptibility": "Typically susceptible to Penicillin, Clindamycin, and Metronidazole."
          },
          "alternative": [
            {
              "drug": "A carbapenem"
            }
          ]
        },
        "comments": {
          "references": "See Eur J Clin Microbiol Infect Dis. 2023:42:903 and Microorganisms. 2021:9:1665 for case series and antimicrobial susceptibilities."
        }
      }
    }
  },
  "additionalData": {
    "antimicrobialStewardship": {
      "sources": [
        "antimicrobial_stewardship",
        "antimicrobialStewardship"
      ],
      "value": []
    },
    "comments": {
      "preservedStructure": {
        "originalFormat": "object",
        "content": {
          "references": "See Eur J Clin Microbiol Infect Dis. 2023:42:903 and Microorganisms. 2021:9:1665 for case series and antimicrobial susceptibilities."
        }
      }
    },
    "diagnosis": {
      "sources": [
        "diagnosis"
      ],
      "value": []
    },
    "allOtherKeys": {
      "last_updated": "2024-04-29",
      "treatment_regimens": {
        "primary": {
          "susceptibility": "Typically susceptible to Penicillin, Clindamycin, and Metronidazole."
        },
        "alternative": [
          {
            "drug": "A carbapenem"
          }
        ]
      }
    }
  }
}